NJ Court Won't Revive Sun Pharma's Contract Breach Suit

Law360, New York (May 13, 2013, 7:57 PM EDT) -- Sun Pharmaceuticals Inc. on Monday failed to reanimate a breach of contract suit against a New Jersey drug research firm after a state appellate court affirmed a trial judge's ruling that there was no evidence of bad faith in a botched deal between the companies.

A three-judge panel on the Superior Court of New Jersey's Appellate Division ruled against Sun, who wanted to revive a suit against East Windsor, N.J.-based Core Tech Solutions Inc., alleging Core Tech breached its contract with the Indian pharmaceutical company for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.